Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone

P Garg, C F Martin, S C Elms, F J Gordon, S M Wall, C J Garland, R L Sutliff, W C O'Neill

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Studies in rat aorta have shown that the Na-K-2Cl cotransporter NKCCl is activated by vasoconstrictors and inhibited by nitrovasodilators, contributes to smooth muscle tone in vitro, and is upregulated in hypertension. To determine the role of NKCCl in systemic vascular resistance and hypertension, blood pressure was measured in rats before and after inhibition of NKCCl with bumetanide. Intravenous infusion of bumetanide sufficient to yield a free plasma concentration above the IC50 for NKCCl produced an immediate drop in blood pressure of 5.2% (P < 0.001). The reduction was not prevented when the renal arteries were clamped, indicating that it was not due to a renal effect of bumetanide. Bumetanide did not alter blood pressure in NKCCl-null mice, demonstrating that it was acting specifically through NKCCl. In third-order mesenteric arteries, bumetanide-inhibitable efflux of Rb-86 was acutely stimulated 133% by phenylephrine, and bumetanide reduced the contractile response to phenylephrine, indicating that NKCC1 influences tone in resistance vessels. The hypotensive effect of bumetanide was proportionately greater in rats made hypertensive by a 7-day infusion of norepinephrine (12.7%, P < 0.001 vs. normotensive rats) but much less so when hypertension was produced by a fixed aortic coarctation (8.0%), again consistent with an effect of bumetanide on resistance vessels rather than other determinants of blood pressure. We conclude that NKCCl influences blood pressure through effects on smooth muscle tone. in resistance vessels and that this effect is augmented in hypertension.
Original languageEnglish
Pages (from-to)H2100-H2105
JournalAmerican Journal of Physiology-Heart and Circulatory Physiology
Volume292
Issue number5
DOIs
Publication statusPublished - 2007

Fingerprint

Member 2 Solute Carrier Family 12
Bumetanide
Smooth Muscle
Blood Pressure
Hypertension
Phenylephrine
Mesenteric Arteries
Aortic Coarctation
Vasoconstrictor Agents
Renal Artery
Intravenous Infusions
Vascular Resistance
Inhibitory Concentration 50
Aorta
Norepinephrine

Cite this

Garg, P., Martin, C. F., Elms, S. C., Gordon, F. J., Wall, S. M., Garland, C. J., ... O'Neill, W. C. (2007). Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone. American Journal of Physiology-Heart and Circulatory Physiology, 292(5), H2100-H2105. https://doi.org/10.1152/ajpheart.01402.2006

Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone. / Garg, P; Martin, C F; Elms, S C; Gordon, F J; Wall, S M; Garland, C J; Sutliff, R L; O'Neill, W C.

In: American Journal of Physiology-Heart and Circulatory Physiology, Vol. 292, No. 5, 2007, p. H2100-H2105.

Research output: Contribution to journalArticle

Garg, P, Martin, CF, Elms, SC, Gordon, FJ, Wall, SM, Garland, CJ, Sutliff, RL & O'Neill, WC 2007, 'Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone', American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 5, pp. H2100-H2105. https://doi.org/10.1152/ajpheart.01402.2006
Garg, P ; Martin, C F ; Elms, S C ; Gordon, F J ; Wall, S M ; Garland, C J ; Sutliff, R L ; O'Neill, W C. / Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone. In: American Journal of Physiology-Heart and Circulatory Physiology. 2007 ; Vol. 292, No. 5. pp. H2100-H2105.
@article{eb7f41db52774249952661306389cf4f,
title = "Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone",
abstract = "Studies in rat aorta have shown that the Na-K-2Cl cotransporter NKCCl is activated by vasoconstrictors and inhibited by nitrovasodilators, contributes to smooth muscle tone in vitro, and is upregulated in hypertension. To determine the role of NKCCl in systemic vascular resistance and hypertension, blood pressure was measured in rats before and after inhibition of NKCCl with bumetanide. Intravenous infusion of bumetanide sufficient to yield a free plasma concentration above the IC50 for NKCCl produced an immediate drop in blood pressure of 5.2{\%} (P < 0.001). The reduction was not prevented when the renal arteries were clamped, indicating that it was not due to a renal effect of bumetanide. Bumetanide did not alter blood pressure in NKCCl-null mice, demonstrating that it was acting specifically through NKCCl. In third-order mesenteric arteries, bumetanide-inhibitable efflux of Rb-86 was acutely stimulated 133{\%} by phenylephrine, and bumetanide reduced the contractile response to phenylephrine, indicating that NKCC1 influences tone in resistance vessels. The hypotensive effect of bumetanide was proportionately greater in rats made hypertensive by a 7-day infusion of norepinephrine (12.7{\%}, P < 0.001 vs. normotensive rats) but much less so when hypertension was produced by a fixed aortic coarctation (8.0{\%}), again consistent with an effect of bumetanide on resistance vessels rather than other determinants of blood pressure. We conclude that NKCCl influences blood pressure through effects on smooth muscle tone. in resistance vessels and that this effect is augmented in hypertension.",
author = "P Garg and Martin, {C F} and Elms, {S C} and Gordon, {F J} and Wall, {S M} and Garland, {C J} and Sutliff, {R L} and O'Neill, {W C}",
note = "ID number: ISI:000247777200011",
year = "2007",
doi = "10.1152/ajpheart.01402.2006",
language = "English",
volume = "292",
pages = "H2100--H2105",
journal = "American Journal of Physiology-Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone

AU - Garg, P

AU - Martin, C F

AU - Elms, S C

AU - Gordon, F J

AU - Wall, S M

AU - Garland, C J

AU - Sutliff, R L

AU - O'Neill, W C

N1 - ID number: ISI:000247777200011

PY - 2007

Y1 - 2007

N2 - Studies in rat aorta have shown that the Na-K-2Cl cotransporter NKCCl is activated by vasoconstrictors and inhibited by nitrovasodilators, contributes to smooth muscle tone in vitro, and is upregulated in hypertension. To determine the role of NKCCl in systemic vascular resistance and hypertension, blood pressure was measured in rats before and after inhibition of NKCCl with bumetanide. Intravenous infusion of bumetanide sufficient to yield a free plasma concentration above the IC50 for NKCCl produced an immediate drop in blood pressure of 5.2% (P < 0.001). The reduction was not prevented when the renal arteries were clamped, indicating that it was not due to a renal effect of bumetanide. Bumetanide did not alter blood pressure in NKCCl-null mice, demonstrating that it was acting specifically through NKCCl. In third-order mesenteric arteries, bumetanide-inhibitable efflux of Rb-86 was acutely stimulated 133% by phenylephrine, and bumetanide reduced the contractile response to phenylephrine, indicating that NKCC1 influences tone in resistance vessels. The hypotensive effect of bumetanide was proportionately greater in rats made hypertensive by a 7-day infusion of norepinephrine (12.7%, P < 0.001 vs. normotensive rats) but much less so when hypertension was produced by a fixed aortic coarctation (8.0%), again consistent with an effect of bumetanide on resistance vessels rather than other determinants of blood pressure. We conclude that NKCCl influences blood pressure through effects on smooth muscle tone. in resistance vessels and that this effect is augmented in hypertension.

AB - Studies in rat aorta have shown that the Na-K-2Cl cotransporter NKCCl is activated by vasoconstrictors and inhibited by nitrovasodilators, contributes to smooth muscle tone in vitro, and is upregulated in hypertension. To determine the role of NKCCl in systemic vascular resistance and hypertension, blood pressure was measured in rats before and after inhibition of NKCCl with bumetanide. Intravenous infusion of bumetanide sufficient to yield a free plasma concentration above the IC50 for NKCCl produced an immediate drop in blood pressure of 5.2% (P < 0.001). The reduction was not prevented when the renal arteries were clamped, indicating that it was not due to a renal effect of bumetanide. Bumetanide did not alter blood pressure in NKCCl-null mice, demonstrating that it was acting specifically through NKCCl. In third-order mesenteric arteries, bumetanide-inhibitable efflux of Rb-86 was acutely stimulated 133% by phenylephrine, and bumetanide reduced the contractile response to phenylephrine, indicating that NKCC1 influences tone in resistance vessels. The hypotensive effect of bumetanide was proportionately greater in rats made hypertensive by a 7-day infusion of norepinephrine (12.7%, P < 0.001 vs. normotensive rats) but much less so when hypertension was produced by a fixed aortic coarctation (8.0%), again consistent with an effect of bumetanide on resistance vessels rather than other determinants of blood pressure. We conclude that NKCCl influences blood pressure through effects on smooth muscle tone. in resistance vessels and that this effect is augmented in hypertension.

UR - http://dx.doi.org/10.1152/ajpheart.01402.2006

U2 - 10.1152/ajpheart.01402.2006

DO - 10.1152/ajpheart.01402.2006

M3 - Article

VL - 292

SP - H2100-H2105

JO - American Journal of Physiology-Heart and Circulatory Physiology

JF - American Journal of Physiology-Heart and Circulatory Physiology

SN - 0363-6135

IS - 5

ER -